Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × pemigatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Cholangiocarcinoma 6 Carcinoma, Transitional Cell 5 Acrocephalosyndactylia 5 Neoplasm Metastasis 3 Gastrointestinal Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Miscellaneous 1 Solid Tumor 1 Sarcoma 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Unknown Primary 1 Myeloproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Locally Advanced Unresectable Gastric Cancer 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Eosinophilia 1

Interventions

Cyclophosphamide 34 fludarabine 29 Tacrolimus 25 Whole-Body Irradiation 22 Mycophenolic Acid 22 Busulfan 21 fludarabine phosphate 19 Melphalan 16 thymoglobulin 14 Antilymphocyte Serum 14 Thiotepa 11 Methotrexate 11 Stem Cell Transplantation 8 Sirolimus 7 Rituximab 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 trametinib 5 ruxolitinib 4 merphos 4 Nivolumab 4 Cytarabine 4 Cyclosporine 4 Cord Blood Stem Cell Transplantation 4 fedratinib 3 ceritinib 3 angiotensin I (1-7) 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Pentostatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡